RNA Analysis/Transcriptomics – Global Market Trajectory & Analytics – ResearchAndMarkets.com

RNA Analysis/Transcriptomics – Global Market Trajectory & Analytics – ResearchAndMarkets.com




RNA Analysis/Transcriptomics – Global Market Trajectory & Analytics – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “RNA Analysis/Transcriptomics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027

Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027.

Microarray, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$754.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PCR segment is readjusted to a revised 13.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12.6% CAGR

The RNA Analysis/Transcriptomics market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 11.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

NGS and Sanger sequencing Segment to Record 14.5% CAGR

In the global NGS and Sanger sequencing segment, USA, Canada, Japan, China and Europe will drive the 14.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$513.2 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027.

Select Competitors (Total 44 Featured):

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • MilliporeSigma
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/y170zc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900